Abstract:Genetic variations in a network of genes involved in DNA double strand breaks (DSB) repair pathway have been shown to increase the risk of breast cancer. XRCC4 is identified as a pivotal modulator in non-homologous end joining (NHEJ), a predominant DSB repair pathway. In this study, we evaluated the associations between single nucleotide polymorphisms (SNPs) in XRCC4 and breast cancer, and investigated the impact of XRCC4A247S variant on nuclear localization and DNA damage response functions of XRCC4. A hospital-based case-control study, comprising 412 breast cancer patients and 458 cancer-free controls recruited from Shanghai Cancer Center, was conducted to investigate the relationship between common polymorphisms in XRCC4 and the risk of breast cancer. Our results showed that XRCC4 A247S polymorphism (rs3734091), located near the putative nuclear localization signal (NLS) of XRCC4, was associated with a significantly increased risk of breast cancer in a recessive genetic model (Adjusted odds ratio (OR) = 1.47, 95% confidence interval (CI) = 1.09-4.52; P = 0.042). This homogeneous variant was more often observed in triple negative subtype (Adjusted OR = 2.07, 95% CI = 1.34 - 3.58 in the recessive model; P = 0.036). Although XRCC4 A247S variant did not harm its interactions with XLF and ligase IV (the other two components of DNA ligase complex), we revealed that A247S alteration partially impaired the nuclear localization of XRCC4 in mammary cells. Remarkably, more evidences implied that XRCC4 A247S variant significantly reduced the in vivo NHEJ repair efficiency compared to the wild-type XRCC4 via colony formation assay and NHEJ reporter assay, suggesting that reduced nuclear accumulation by XRCC4 A247S variant impaired its functions in response to DNA damage. Importantly, XRCC4 A247S alternation promoted cellular sensitivity to ionizing radiation and DNA damaging agents in chemotherapy. Taken together, this study demonstrates that genetic variation of XRCC4 A247S could impair NHEJ mediated DSB repair and provide further evidences that genetic variants involved in DNA repair pathways contribute to breast cancer susceptibility. In addition, our results also indicate that XRCC4 A247S variant might be a potential predictive biomarker and therapeutic target in breast cancer. Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P2-07-01.

A Recessive Variant Of Xrcc4 Predisposes To Non-Brca1/2 Breast Cancer In Chinese Women And Impairs The Dna Damage Response Via Dysregulated Nuclear Localization

Association of single nucleotide polymorphisms and haplotypes in DNA repair gene XRCC1 with susceptibility of breast cancer]

Correlations of Single Nucleotide Polymorphisms of DNA Repair Gene XRCC1 to Risk of Colorectal Cancer

Susceptibility of XRCC3, XPD, and XPG genetic variants to cervical carcinoma.

[Association of XPC gene polymorphisms with breast cancer risk].

Abstract P2-07-01: Polymorphism A247S of XRCC4 contributes to the risk of breast cancer and impairs DNA damage repair pathway

A Single Nucleotide Polymorphism in XRCC4 Gene is Associated with Reduced Colorectal Cancer Susceptibility in Female

Association of a Novel Genetic Variant in RP11-650L12.2 with Risk of Colorectal Cancer in Han Chinese Population.

Prevalence and Reclassification of BRCA1 and BRCA2 Variants in a Large, Unselected Chinese Han Breast Cancer Cohort

The Nonsynonymous Single Nucleotide Polymorphisms of Dna Repair Gene Xrcc1 and Susceptibility to the Development of Cervical Carcinoma and High-Risk Human Papillomavirus Infection

DNA Repair Gene XRCC3 Polymorphisms and Cancer Risk: a Meta-Analysis of 48 Case–control Studies

XRCC3 5′-UTR and IVS5-14 Polymorphisms and Breast Cancer Susceptibility: a Meta-Analysis

XRCC 1 Arg 399 Gln , Arg 194 Trp and Arg 280 His polymorphisms in breast cancer risk : a meta-analysis

A Population-Based Case-Control Study of the Arg399Gln Polymorphism in DNA Repair Gene XRCC1 and Risk of Breast Cancer.

Genetic Polymorphisms of DNA Repair Genes XPD, XPC, and XRCC4 in Relation to Colorectal Cancer Susceptibility

DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case|[ndash]|control studies

XRCC1 Arg399Gln, Arg194Trp and Arg280His Polymorphisms in Breast Cancer Risk: a Meta-Analysis.

A meta-analysis on XRCC1 and XRCC3 polymorphisms and colorectal cancer risk

Polymorphisms In Excision Repair Cross-Complementing Group 4 (Ercc4) And Susceptibility To Primary Lung Cancer In A Chinese Han Population

A Novel T-77C Polymorphism in DNA Repair Gene XRCC1 Contributes to Diminished Promoter Activity and Increased Risk of Non-Small Cell Lung Cancer

Differences of Variable Number Tandem Repeats in XRCC5 Promoter Are Associated with Increased or Decreased Risk of Breast Cancer in BRCA Gene Mutation Carriers